Save the date for September’s LEADDD Network session— a panel conversation with Dr. Beth Stewart, Missouri, assistant member of the Department of Oncology at St. Jude Children’s Research Hospital, and researcher Hillary Husband, Louisiana Tech, in honor of National Childhood Cancer Awareness Month.
Already a member of LEADDD Network? Check your email or the CONNECTDDD group for the Zoom link.
Tuesday, Sept. 26
12:00 p.m. CT
Hillary Husband, Louisiana Tech, is a pharmaceutical/biomedical researcher, a three-time cancer survivor, a former St. Jude patient, and a Tri Delta woman. She joined Metrum Research Group in 2021after earning her BS in Chemistry from Louisiana College and her MS in Mathematics and Ph.D. in Engineering from Louisiana Tech University. Hillary’s work centers around pharmacokinetic/pharmacodynamic (PK/PD) modeling of clinical trial data to support regulatory submissions for new drugs and new applications of existing drugs across a range of therapeutic areas – including pediatrics and oncology programs.
Dr. Elizabeth “Beth” Stewart, Missouri, is an assistant member of the Department of Oncology at St. Jude Children’s Research Hospital. Beth originally came to St. Jude as a clinical fellow in 2010, and she completed her Hematology-Oncology Fellowship training in 2014. Clinical fellows at St. Jude are encouraged to gain experience in a research lab, and she joined the lab of Dr. Michael Dyer. After working within the lab, she was so captivated by the prospective scientific discoveries that she decided to devote more of her time to investigating high-risk pediatric solid tumors.
One of her first research projects involved looking for new therapy options for Ewing sarcoma, a type of pediatric bone cancer. After studying drug screens and combinations in laboratory models, Beth discovered new drug combinations with PARP inhibitors that worked well against Ewing sarcoma. Because of this success, these new combinations of drugs are now being used in several clinical trials for patients with high-risk Ewing sarcoma.
Today, Beth continues with research in her own laboratory, specifically focusing on childhood solid tumors such as Ewing sarcoma, rhabdomyosarcoma and osteosarcoma. Her primary focus is to look for new therapy options for these tumors, and her work has been published in several high-profile peer-reviewed journals and contributed to several clinical trials. She also plays an integral role in the Childhood Solid Tumor Network, the world’s largest and most comprehensive collection of scientific resources for researchers studying pediatric solid tumors. In addition to her work in the lab, she continues to treat patients in the solid tumor clinic at St. Jude.
She is originally from Peoria, Illinois, and has supported the life-saving work at St. Jude through her research and care of patients as well as by participating in the Memphis to Peoria Run for the past 15 years.